|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.7 PLN | -2.00% |
|
-3.76% | -23.90% |
| 05-17 | Molecure S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 03-22 | Molecure S.A. Announces First Patient in the OATD-01 Phase 2 KITE Study in Pulmonary Sarcoidosis | CI |
Effective April 04, 2022, ONCOARENDI THERAPEUTICS S.A will change its name to Molecure S.A.
| 1st Jan change | Capi. | |
|---|---|---|
| -23.90% | 64.58M | |
| +9.83% | 115B | |
| +10.80% | 105B | |
| -10.84% | 22.71B | |
| -1.11% | 21.83B | |
| -11.21% | 18.18B | |
| -41.92% | 16.52B | |
| -15.11% | 16.01B | |
| +6.62% | 14.14B | |
| +17.53% | 10.71B |
MOLECURE S.A. 
